| Published in Scientific Journal Molecular Aspects of Medicine SALT LAKE CITY, Nov. 10, 2011 (GLOBE NEWSWIRE) -- LifeVantage Corporation (OTCBB:LFVN), the maker of science-based solutions to oxidative stress, announced today that a new peer-reviewed study involving its flagship product, Protandim ® , has been published in the scientific journal Molecular Aspects of Medicine . The new paper takes a historical look at the field of biological antioxidants and oxidative stress, examines gene regulation...continued LFVN Drugs Healthcare barrier |
Thursday, November 10, 2011
LifeVantage Announces New Peer-Reviewed Study Involving Protandim(R)
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment